Management Sciences for Health, Medford, Massachusetts, USA.
Universitas Gadjah Mada, Yogyakarta.
Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1041-1048. doi: 10.5588/ijtld.16.0898.
Indonesia has a high prevalence of tuberculosis (TB) and is one of the 22 countries with the highest TB burdens in the world.
To understand the economic burden of TB in Indonesia.
TB data for 2015 were combined with cost data using a simple type of cost-benefit analysis in a decision tree model to show the economic burden under different scenarios.
In Indonesia, there were an estimated 1 017 378 new active TB cases in 2015, including multidrug-resistant TB. It is estimated that 417 976 of these cases would be treated and cured, 160 830 would be unsuccessfully treated and would die, 131 571 would be untreated and would achieve cure spontaneously, and 307 000 would be untreated and would die. The total economic burden related to treated and untreated cases would be approximately US$6.9 billion. Loss of productivity due to premature death would be by far the largest element, comprising US$6.0 billion (discounted), which represents 86.6% of the total cost. Loss of productivity due to illness would be US$700 million (10.1%), provider medical costs US$156 million (2.2%), and direct non-medical costs incurred by patients and their households US$74 million (1.1%).
The economic burden of TB in Indonesia is extremely high. Detecting and treating more cases would result not only in major reductions in suffering but also in economic savings to society.
印度尼西亚的结核病（TB）发病率很高，是全球 22 个结核病负担最重的国家之一。
了解印度尼西亚结核病的经济负担。
使用决策树模型中的一种简单成本效益分析方法，将 2015 年的结核病数据与成本数据相结合，展示不同情况下的经济负担。
2015 年，印度尼西亚估计有 1017378 例新的活动性结核病病例，包括耐多药结核病。据估计，其中 417976 例将得到治疗和治愈，160830 例将治疗失败并死亡，131571 例未经治疗将自行治愈，307000 例未经治疗将死亡。与治疗和未治疗病例相关的总经济负担约为 69 亿美元。由于过早死亡导致的生产力损失将是最大的因素，占 60 亿美元（折现），占总成本的 86.6%。因疾病导致的生产力损失为 7 亿美元（10.1%），提供者医疗费用为 1.56 亿美元（2.2%），患者及其家庭的直接非医疗费用为 7400 万美元（1.1%）。
印度尼西亚结核病的经济负担极高。检测和治疗更多病例不仅会大大减轻痛苦，还会为社会节省经济成本。
